Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease have?
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease has 65 citations in the OpenAlex counts ScholarIQ stores.
When was Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease published?
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease has 2022 year in the ScholarIQ index.
What is the open-access status of Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease?
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease has green oa status in the ScholarIQ index.
What is the DOI of Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease?
The DOI for Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease is on the source record.
What is the PMID of Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease?
The PMID for Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease is on the source record.
What is the OpenAlex record for Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease?
The OpenAlex for Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease is on the source record.